Linden Thomas Advisory Services, LLC Seagen Inc. Transaction History

Linden Thomas Advisory Services, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 20, 2023	SELL	$191.51 - $216.16 $1.28 Million - $1.44 Million	-6,679 Reduced 61.46%	4,189 $889 Million
Q2 2023 Jul 27, 2023	BUY	$187.64 - $206.25 $115,961 - $127,462	618 Added 6.03%	10,868 $2.09 Billion
Q1 2023 Apr 24, 2023	BUY	$127.59 - $203.08 $96,458 - $153,528	756 Added 7.96%	10,250 $2.08 Billion
Q4 2022 Feb 16, 2023	BUY	$117.37 - $139.17 $1.11 Million - $1.32 Million	9,494 New	9,494 $1.22 Billion

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Linden Thomas Advisory Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Linden Thomas Advisory Services, LLC with notifications on news.